DCM
RXDX

Driehaus Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Driehaus Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-267,399
Closed -$28.7M – 488
2023
Q1 		$28.7M Sell
267,399
-3,680
-1% -$395K 0.4% 69
2022
Q4 		$29.8M Buy
+271,079
New +$29.8M 0.44% 67